Facebook
Twitter
LinkedIn
Forward
Over the last decade, the FDA has approved five new medications for the treatment of obesity. The latest edition, semaglutide, published impressive weight loss results and we are just beginning.
|
Our patients frequently ask if they should take CBD to assist with weight loss.
|
Akkermansia muciniphila, a key player in the gut microbiome, has emerged as a significant influencer of GLP-1, a hormone with profound implications for metabolic health.
|
Many factors influence a patient's weight loss journey including metabolism, genetics, lifestyle, and other biological and cultural differences.
|
Join us for an informative session designed to enhance your expertise in prescribing GLP1 medications for the treatment of obesity.
|
Obesity is a metabolic disease that requires lifelong lifestyle changes and in many patients who are overweight or obese, prescription medication.
|
Telemedicine offers a unique opportunity to expand access to obesity care.
|
Join us for an insightful debate on the most effective approaches to treating obesity in children.
|
As the choices available for anti-obesity pharmacotherapy increase, clinicians are faced with options for addressing key clinical scenarios.
|
Selecting the correct on label or off label medication to treat obesity can be confusing. The acronym RXAOM provides a framework for individualizing the selection process.
|
Pages
- « first
- ‹ previous
- 1
- 2
- 3